Kikuchi N, Kawashima T, Onozaki I
Department of Internal Medicine, Chiba Kaihin Municipal Hospital.
Jpn J Antibiot. 1990 Jan;43(1):100-4.
We studied the clinical efficacy of ofloxacin (OFLX) in the treatment of 13 cases of Mycoplasma pneumoniae pneumonia. OFLX was given to each patient orally at 200 mg/dose, 3 doses daily. One case was excluded because of a side effect i.e., nausea. In 12 evaluable cases, the clinical efficacy rate was 100% i.e., excellent in 7, good in 5. OFLX is one of the useful drugs in the treatment of M. pneumoniae pneumonia.
我们研究了氧氟沙星（OFLX）治疗13例肺炎支原体肺炎的临床疗效。给予每位患者口服氧氟沙星，剂量为200毫克/次，每日3次。有1例因出现恶心副作用而被排除。在12例可评估病例中，临床有效率为100%，即7例为优，5例为良。氧氟沙星是治疗肺炎支原体肺炎的有效药物之一。
